ArticleNeuro-oncology advances

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases.

Anna Sophie Berghoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.